Madrigal Pharmaceuticals announced it will participate in live fireside chats at three upcoming investor conferences: Jefferies Global Healthcare Conference in London on Nov 17, Evercore Healthcare Conference on Dec 1, and Piper Sandler Healthcare Conference on Dec 2. These events provide Madrigal an opportunity to update investors on its progress, particularly regarding its liver disease drug Rezdiffra, which is FDA and European Commission approved for MASH treatment. The company is also conducting a Phase 3 trial for Rezdiffra in advanced MASH cirrhosis. Investors can watch the webcasts via Madrigal's Investor Relations page.
Madrigal Pharmaceuticals is set to participate in three upcoming investor conferences. For readers following the health sector, here is Pluang's market snapshot as of Nov 13, 2026 19:41 WIB: out of 150 priced US health stocks, 99 rose and 43 fell today. Notable movers include AHCO at USD 7.68 with a 1-day change of -2.41% and 100% sell order activity, NVAX at USD 8.96 with a 1-day change of +2.28% and 99% buy order activity, and COO at USD 63.52 with a 1-day change of +2.14%.
KeyBanc lowered its price target for YETI Holdings to $49, suggesting a 27.94% upside from the current $38.30 stock price. This follows YETI's reduction of its full-year adjusted sales growth forecast to about 6% from the previous 7-8%, citing consum...
Bernstein SocGen Group has reduced its price target for Applied Materials to $600, even though the company reported higher sales and profits in Q4 2026 driven by strong demand for semiconductor services, especially AI chips. Applied Materials posted ...
Boralex Inc. announced a private placement of $600 million Canadian dollars in green bonds, split into two series maturing in 2031 and 2036 with interest rates of 4.503% and 5.173%, respectively. This marks Boralex's first issuance of green corporate...
Boralex Inc. announced the issuance of C$600 million in green bonds, split into two series with maturities in 2031 and 2036, bearing interest rates of 4.503% and 5.173% respectively. This marks Boralex's first green-labelled corporate securities offe...
Investec Bank Plc, acting as an exempt principal trader and advisor to DBAY Advisors Limited, disclosed the sale of 25,000 ordinary shares of Logistics Development Group Plc on November 12, 2026. The shares were sold at a price of 23 per unit. There ...
